Department of Community Pharmacy, Faculty of Pharmacy, Silpakorn University, Muang, Nakhon Pathom, Thailand.
Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Health Care Women Int. 2021;42(4-6):503-517. doi: 10.1080/07399332.2020.1817025. Epub 2020 Sep 17.
Implementation of preconception care interventions have been encouraged for improving maternal and child health outcomes; therefore, evidence on their cost-effectiveness is needed. We conducted the systematic review to examine the efficiency of those interventions by collecting evidence from published economic evaluation studies. Out of 14 included studies, almost all (12/14) were in high-income countries. All studies were not cost-utility analysis with genetic disease screening and diabetes management were the common interventions for evaluating their efficiency during preconception period. Preconception care interventions are likely to be cost-effective, especially in low-income countries which incremental benefits had a greater return than developed nations.
已鼓励实施孕前保健干预措施,以改善母婴健康结果;因此,需要有其成本效益的证据。我们通过收集已发表的经济评估研究中的证据来进行系统评价,以检查这些干预措施的效率。在纳入的 14 项研究中,几乎所有(12/14)都来自高收入国家。所有研究均非成本效用分析,其中常见的干预措施是在孕前阶段对遗传疾病筛查和糖尿病管理进行评估。孕前保健干预措施可能具有成本效益,尤其是在低收入国家,其增量效益的回报大于发达国家。